home / stock / crsp / crsp quote
Last: | $54.56 |
---|---|
Change Percent: | 0.23% |
Open: | $56.08 |
Close: | $54.56 |
High: | $56.21 |
Low: | $54.01 |
Volume: | 1,389,446 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$54.56 | $56.08 | $54.56 | $56.21 | $54.01 | 1,389,446 | 07-19-2024 |
$56.21 | $60.84 | $56.21 | $61.47 | $55.82 | 1,957,678 | 07-18-2024 |
$60.48 | $61.14 | $60.48 | $63.3899 | $60.26 | 1,588,371 | 07-17-2024 |
$62.75 | $57.72 | $62.75 | $63.68 | $57.4201 | 3,079,410 | 07-16-2024 |
$57.46 | $57.95 | $57.46 | $58.46 | $56.5 | 1,018,361 | 07-15-2024 |
$57.9 | $57.38 | $57.9 | $58.84 | $56.635 | 1,388,805 | 07-12-2024 |
$56.81 | $57.38 | $56.81 | $60.2 | $56.57 | 1,976,409 | 07-11-2024 |
$55.56 | $55.52 | $55.56 | $55.94 | $54.09 | 911,038 | 07-10-2024 |
$55.03 | $53.25 | $55.03 | $55.15 | $52.83 | 904,889 | 07-09-2024 |
$53.23 | $53.66 | $53.23 | $54.8286 | $53.17 | 1,051,596 | 07-08-2024 |
$53.1 | $53.69 | $53.1 | $53.69 | $52.31 | 1,078,291 | 07-05-2024 |
$53.9 | $53.6 | $53.9 | $54.74 | $53.14 | 679,450 | 07-04-2024 |
$53.9 | $53.6 | $53.9 | $54.74 | $53.14 | 679,450 | 07-03-2024 |
$53.115 | $53.98 | $53.115 | $53.98 | $52.52 | 1,058,986 | 07-02-2024 |
$53.95 | $54.02 | $53.95 | $55.67 | $53.3105 | 1,292,722 | 07-01-2024 |
$54.01 | $55.53 | $54.01 | $55.6916 | $53.33 | 1,313,469 | 06-28-2024 |
$55.38 | $56.66 | $55.38 | $57.98 | $55.31 | 1,236,984 | 06-27-2024 |
$56.63 | $55.47 | $56.63 | $56.8 | $55.01 | 1,048,932 | 06-26-2024 |
$55.95 | $57.71 | $55.95 | $57.97 | $55.68 | 873,115 | 06-25-2024 |
$57.94 | $56.27 | $57.94 | $58.31 | $56.11 | 1,097,053 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website:
2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...